Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Weill Medical College of Cornell University |
---|---|
Information provided by: | Weill Medical College of Cornell University |
ClinicalTrials.gov Identifier: | NCT00801996 |
This protocol is designed to collect a small amount of blood and tissue from individuals with prostate cancer for extraction of DNA (genetic material) for the study of the genetic basis of prostate cancer. The study population will include individuals with known prostate cancer and controls without prostate cancer. The study will be conducted in Doha, Qatar at the Hamad Medical Corporation and Weill Cornell Medical College (Qatar). Individuals in the study population will be of Arab descent from Qatar. In this protocol, researchers will survey epidemiologic factors and medical records of patients with prostate cancer in order to study the clinical characteristics of these individuals. The researchers will collect blood and tissue samples to evaluate the genetic characteristics of individuals with prostate cancer. The researchers will also collect blood samples of individuals without prostate cancer to serve as a control. The goal will be to identify genes that are associated with prostate cancer and gene profiles that are associated with differing prognoses in individuals who have prostate cancer.
Condition |
---|
Prostate Cancer |
Study Type: | Observational |
Study Design: | Case Control, Cross-Sectional |
Official Title: | Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries |
Blood and tissue will be collected from individuals with prostate cancer. Only blood will be collected from normal controls.
Estimated Enrollment: | 700 |
Study Start Date: | November 2008 |
Estimated Study Completion Date: | November 2011 |
Estimated Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
1. Prostate Cancer
Inclusion Criteria:
Exclusion Criteria: • Patient refuses consent |
2. Normal Healthy Controls
Inclusion Criteria:
Exclusion Criteria:
|
Ages Eligible for Study: | 40 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion/Exclusion Criteria for Normal Cohort
Inclusion Criteria:
Exclusion Criteria:
Inclusion/Exclusion Criteria for Prostate Cohort
Inclusion Criteria:
Exclusion Criteria:
• Patient refuses consent
Qatar | |
Weill Cornell Medical College - Qatar | Recruiting |
Doha, Qatar | |
Contact: Amani Ma'ayah, MS, Pharm. 011-974-492-8405 asm2004@qatar-med.cornell.edu | |
Principal Investigator: Lotfi Chouchange, PhD |
Responsible Party: | Weill Cornell Medical College ( Dr. Alvin Mushlin ) |
Study ID Numbers: | 0806009874 |
Study First Received: | November 14, 2008 |
Last Updated: | December 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00801996 |
Health Authority: | United States: Institutional Review Board; Qatar: Study Coordinator, WCMC - Qatar |
prostate cancer genetics |
Prostatic Diseases Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |
Neoplasms Neoplasms by Site |